Drugs / HY001N
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT07265206 | Dec 2025 → Dec 2026 expected | autoimmune disorder of the nervous system | Juventas Cell Therapy Ltd. | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HY001N | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07265206 ↗ |
| Modality | Cell therapy | “HY001N cell injection” NCT07265206 ↗ |